| 1 |
30702971 | Celecoxib With Neoadjuvant Chemotherapy for Breast Cancer Might Worsen Outcomes Differentially by COX-2 Expression and ER Status: Exploratory Analysis of the REMAGUS02 Trial. | 2019 Mar 10 |
1 |
| 2 |
30066906 | Efficacy of gefitinib‑celecoxib combination therapy in docetaxel‑resistant prostate cancer. | 2018 Oct |
4 |
| 3 |
24741455 | Curcumin Enhances Docetaxel-Induced Apoptosis of 8505C Anaplastic Thyroid Carcinoma Cells. | 2014 Mar |
1 |
| 4 |
24155892 | Combined inhibition of epidermal growth factor receptor and cyclooxygenase-2 leads to greater anti-tumor activity of docetaxel in advanced prostate cancer. | 2013 |
1 |
| 5 |
19456779 | Improvement in docetaxel-induced nail changes associated with cyclooxygenase-2 inhibitor treatment. | 2009 Oct |
1 |
| 6 |
17505004 | Enhancement of docetaxel-induced cytotoxicity by blocking epidermal growth factor receptor and cyclooxygenase-2 pathways in squamous cell carcinoma of the head and neck. | 2007 May 15 |
3 |
| 7 |
16983095 | Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel. | 2006 Sep 26 |
3 |
| 8 |
15835749 | Formulation and evaluation of aerosolized celecoxib for the treatment of lung cancer. | 2005 Mar |
3 |
| 9 |
16166442 | Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel. | 2005 Sep 15 |
2 |
| 10 |
12826679 | Regulation of cyclooxgenase-2 mRNA stability by taxanes: evidence for involvement of p38, MAPKAPK-2, and HuR. | 2003 Sep 26 |
3 |
| 11 |
11895918 | Cyclooxygenase-2 induction by paclitaxel, docetaxel, and taxane analogues in human monocytes and murine macrophages: structure-activity relationships and their implications. | 2002 Mar |
2 |
| 12 |
9886421 | Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme. | 1999 Jan 1 |
1 |